JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Saved in:
| Title: | JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors. |
|---|---|
| Authors: | Pennel, Kathryn A. F.1 (AUTHOR) kathryn.pennel@glasgow.ac.uk, Hatthakarnkul, Phimmada1 (AUTHOR), Wood, Colin S.1,2 (AUTHOR), Lian, Guang-Yu1 (AUTHOR), Al-Badran, Sara S. F.1 (AUTHOR), Quinn, Jean A.1 (AUTHOR), Legrini, Assya1 (AUTHOR), Inthagard, Jitwadee1 (AUTHOR), Alexander, Peter G.2 (AUTHOR), van Wyk, Hester2 (AUTHOR), Kurniawan, Ahmad1 (AUTHOR), Hashmi, Umar1,3 (AUTHOR), Gillespie, Michael A.4 (AUTHOR), Mills, Megan4 (AUTHOR), Ammar, Aula1 (AUTHOR), Hay, Jennifer5 (AUTHOR), Andersen, Ditte6 (AUTHOR), Nixon, Colin4 (AUTHOR), Rebus, Selma1 (AUTHOR), Chang, David K.1,2 (AUTHOR) |
| Source: | Journal of Experimental & Clinical Cancer Research (17569966). 3/1/2024, Vol. 43 Issue 1, p1-20. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
